07-12-2024 Dr. Jianpeng Wang, Senior Director of GMP Manufacturing, GenScript
Monoclonal antibodies (mAbs) have become essential in treating a wide spectrum of diseases, with over 100 therapeutic antibody products now approved and commercially available.
06-21-2024 Dr. Carter Hao
The webinar will introduce the advantages of bispecific antibodies (bsAbs), their mechanism of action (MOA), and the development history of bsAb platform.
06-18-2024 Dr. Wang Sai, Senior Scientist (Protein), GenScript
In vitro transcribed (IVT) mRNA has emerged as a powerful therapeutic and preventive modality that can offer solutions for infectious diseases, cancer, monogenic disorders, and more.
05-22-2024 Dr. Yerim Kwon, Field Application Scientist, APAC region
Multi-transmembrane proteins, especially G-protein coupled receptors (GPCRs), are extremely difficult to develop antibodies against due to their low expression levels, insolubility in vitro, unstable purification and difficulty in maintaining their native
05-10-2024 Dr. Tingting Xiao, Antibody Senior Scientist, GenScript
FREE WEBINAR! CRISPR screens decode human T cell function
04-17-2024 Ralf Schmidt, MD Department of Laboratory Medicine Medical University of Vienna